Marzia Mare

Catania, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Continuum of care and survival in patients with metastatic colorectal cancer: results of the real-world prospective, longitudinal cohort PROMETCO study.

Continuum of care and survival in patients with metastatic colorectal cancer: results of the real-world prospective, longitudinal cohort PROMETCO study.

Journal: ESMO gastrointestinal oncology
Published: February 06, 2026

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

An open-source clinical bioinformatics pipeline for real-world NGS implementation: translating genomic variants into actionable treatment strategies in oncology.

An open-source clinical bioinformatics pipeline for real-world NGS implementation: translating genomic variants into actionable treatment strategies in oncology.

Journal: Journal of translational medicine
Published: September 30, 2025

Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Journal: Clinical and experimental medicine
Published: July 29, 2025

Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal Cancer.

Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal Cancer.

Journal: Biomolecules
Published: July 21, 2025

Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Journal: Clinical and experimental medicine
Published: May 29, 2025

Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.

Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.

Journal: Journal of translational medicine
Published: May 03, 2024

ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation.

ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation.

Journal: Cancers
Published: April 02, 2024

Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.

Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.

Journal: Cancers
Published: December 07, 2023

Interleukin-21 Influences Glioblastoma Course: Biological Mechanisms and Therapeutic Potential.

Interleukin-21 Influences Glioblastoma Course: Biological Mechanisms and Therapeutic Potential.

Journal: Cells
Published: August 10, 2023

Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.

Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.

Journal: Journal of translational medicine
Published: July 21, 2023

Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Journal: Cancers
Published: April 17, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026